Drug-resistant TB in Afghanistan: We must continue to put people at the centre of treatment

In recent years, Médecins Sans Frontières (MSF) has been able to improve patients' experiences of care for drug-resistant TB in Afghanistan, but the changing political situation in the country threatens to derail this progress. Anita Mesic, MSF TB, HIV, and hepatitis adviser reports in The BMJ.

To subscribe to the Weekly Newsletter of new posts, enter your email here:

By Anita Mesic

Published: Jan. 10, 2022, 6:01 p.m.

Last updated: Jan. 16, 2022, 6:06 p.m.

Print Share